세계의 심장박동관리 기기 시장 규모, 점유율, 동향 분석 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Cardiac Rhythm Management Devices Market Summary

The global cardiac rhythm management devices market size was estimated at USD 14.41 billion in 2024 and is projected to reach USD 18.77 billion by 2033, growing at a CAGR of 2.92% from 2025 to 2033. Various technological advancements related to the market, such as the integration of AI, remote monitoring, and wearable technology, are anticipated to fuel the market growth.

The growing prevalence of various cardiovascular diseases, such as arrhythmia and atrial fibrillation, among others. According to the Centers for Disease Control and Prevention (CDC), around 12.1 million people in the U.S. are expected to suffer from atrial fibrillation (AFib) by 2030.

The widespread impact of cardiovascular disease (CVD) is a key aspect boosting the growth and innovation within the cardiac monitoring and cardiac rhythm management devices market. According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches about 7,179 cases per 100,000 people, underscoring the significant and ongoing impact of heart conditions globally. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. This fuels demand for cardiac monitoring and cardiac rhythm management devices, critical for identifying abnormal heart rhythms, managing chronic heart conditions, and reducing the risk of serious cardiac events

Global Cardiac Rhythm Management Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cardiac rhythm management devices market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Pacemakers
  • Conventional
  • Leadless
• Defibrillators
  • Implantable Cardioverter Defibrillators (ICD)
  • Single Chamber
  • Dual Chamber
  • External Defibrillator
  • Manual External Defibrillator
  • Automatic External Defibrillator
  • Wearable Cardioverter Defibrillator
• Cardiac Resynchronization Therapy (CRT)
  • CRT-defibrillator
  • CRT-pacemakers
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology And Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Cardiac Rhythm Management Devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Cardiac Rhythm Management Devices Market Segment Analysis, By Product 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Cardiac Rhythm Management Devices Market By Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 4.5.1. Pacemakers
    • 4.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.1.1.1. Conventional
        • 4.5.1.1.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.1.1.2. Leadless
        • 4.5.1.1.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 4.5.2. Defibrillators
    • 4.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.2.1.1. Implantable Cardioverter Defibrillators (ICD)
        • 4.5.2.1.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.1.1.1.1. Single Chamber
            • 4.5.2.1.1.1.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.1.1.1.2. Dual Chamber
            • 4.5.2.1.1.1.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.2.1.2. External Defibrillator
        • 4.5.2.1.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.1.2.1.1. Manual External Defibrillator
            • 4.5.2.1.2.1.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.1.2.1.2. Automatic External Defibrillator
            • 4.5.2.1.2.1.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.1.2.1.3. Wearable Cardioverter Defibrillator
            • 4.5.2.1.2.1.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 4.5.3. Cardiac Resynchronization Therapy (CRT)
    • 4.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.3.1.1. CRT-Defibrillator
        • 4.5.3.1.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.3.1.2. CRT-Pacemakers
        • 4.5.3.1.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 5. Cardiac Rhythm Management Devices Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Cardiac Rhythm Management Devices Market By End Use Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 5.5.1. Hospitals
    • 5.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.5.2. Ambulatory Surgery Centers
    • 5.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.5.3. Others
    • 5.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Cardiac Rhythm Management Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Cardiac Rhythm Management Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America Cardiac Rhythm Management Devices Market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. U.S. Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Canada Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Canada Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. UK Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Germany Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.4. Spain
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Spain Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.5. France
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. France Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.6. Italy
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Italy Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Denmark Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Sweden Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Norway Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory Framework
    • 6.7.1.4. Japan Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. China Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. India Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.7.4. South Korea
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. South Korea Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.7.5. Thailand
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Thailand Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Australia Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Cardiac Rhythm Management Devices Market, 2021 - 2033 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Brazil Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Argentina Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. MEA Cardiac Rhythm Management Devices Market, 2021 - 2033 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. South Africa Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Saudi Arabia Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. UAE Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Kuwait Cardiac Rhythm Management Devices Market, 2021 To 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Physio-Control, Inc.
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Medtronic, plc
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. ABBOTT
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Boston Scientific Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Schiller
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Koninklijke Philips N.V
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Biotronik
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Progetti Srl
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Zoll Medical Corporation
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. LivaNova Plc
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives